EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $707 | -79.5% | 2,320 | -52.5% | 0.00% | – |
Q2 2023 | $3,441 | +6782.0% | 4,888 | -91.2% | 0.00% | – |
Q1 2023 | $50 | -21.9% | 55,477 | +2.8% | 0.00% | – |
Q4 2022 | $64 | -100.0% | 53,990 | -0.7% | 0.00% | -100.0% |
Q3 2022 | $409,000 | +27.4% | 54,367 | +6.6% | 0.00% | – |
Q2 2022 | $321,000 | +1.6% | 51,020 | +33.8% | 0.00% | – |
Q1 2022 | $316,000 | +56.4% | 38,130 | -2.0% | 0.00% | – |
Q4 2021 | $202,000 | -23.5% | 38,905 | -1.6% | 0.00% | – |
Q3 2021 | $264,000 | -19.5% | 39,540 | +2.8% | 0.00% | – |
Q2 2021 | $328,000 | +40.2% | 38,461 | +45.2% | 0.00% | – |
Q1 2021 | $234,000 | -32.2% | 26,487 | -5.6% | 0.00% | – |
Q4 2020 | $345,000 | +71.6% | 28,067 | +13.9% | 0.00% | – |
Q3 2020 | $201,000 | -23.6% | 24,637 | -10.2% | 0.00% | – |
Q2 2020 | $263,000 | +74.2% | 27,437 | +23.5% | 0.00% | – |
Q1 2020 | $151,000 | -55.6% | 22,221 | -2.5% | 0.00% | -100.0% |
Q4 2019 | $340,000 | +53.8% | 22,799 | +5.8% | 0.00% | – |
Q3 2019 | $221,000 | -0.9% | 21,556 | +2.5% | 0.00% | – |
Q2 2019 | $223,000 | – | 21,037 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
DRW Securities, LLC | 120,365 | $37 | 0.00% |
DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |